Oregon launches initiative to help equip workplaces with overdose drug

The Oregon Health Authority on Monday announced the launch of Reverse Overdose Oregon, which connects employers to training and tools to recognize when someone is overdosing on opioids and to administer naloxone, an overdose reversal medication. “Most workplaces are already equipped with fire extinguishers and AEDs,” said OHA Chief Medical Director Dr. Dana Hargunani. “We hope this pilot project will inspire more employers to build life-saving naloxone into the way they prepare for emergencies…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news

Related Links:

New York City managers of businesses like restaurants, bars, and convenience stores need -- and want -- training to recognize drug overdoses and instruction on how to treat them with naloxone.Medscape Medical News
Source: Medscape Emergency Medicine Headlines - Category: Emergency Medicine Tags: Psychiatry News Source Type: news
BACKGROUND: Overdose education and naloxone distribution programs decrease opioid overdose deaths. However, no studies of such programs have been carried out in Denmark. The aim of this study was to evaluate the feasibility and the effect of a broader "tra...
Source: SafetyLit - Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
(American Osteopathic Association) A new article outlines common drug-drug interactions that alter how the body metabolizes certain opioids, causing decreased efficacy that ultimately can lead to misuse and overdose. The authors estimate that around 30 percent of patients experience such interactions; however, very few are detected and reported.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
Chris Pennington, 35, of Michigan, passed away on June 1 after a fatal overdose from cocaine laced with fentanly. His sister-in-law Nichole Cicotte shared a photo of the family saying goodbye.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
This article provides an overview of the advantages and limitations of these specific harm‐reduction strategies and provides guidance on how to practically utilize them when caring for patients with cancer pain.Implications for Practice.Treating cancer pain has important and unique considerations compared with other chronic, noncancer pain disorders. The use of risk mitigation strategies for opioid prescribing as promoted by the Centers for Disease Control and Prevention does not translate seamlessly to patients with cancer. It is crucial to be wary of the advantages and pitfalls of all risk mitigation strategies related...
Source: The Oncologist - Category: Cancer & Oncology Authors: Tags: Symptom Management and Supportive Care Cancer Care and the Opioid Crisis Source Type: research
American Journal of Psychiatry, Ahead of Print.
Source: American Journal of Psychiatry - Category: Psychiatry Authors: Source Type: research
(Penn State) Opioid overdoses take the lives of tens of thousands of Americans annually. Two researchers from Penn State College of Medicine have received nearly $5 million from the National Institutes of Health (NIH) to study whether an already-approved drug can be used to reduce cravings and prevent relapse in those struggling with opioid addiction.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
(Iowa State University) A recently published study shows the United States in the grip of several simultaneously occurring opioid epidemics, rather than just a single crisis. The epidemics came to light after the researchers analyzed county-level data on drug overdose deaths. The study highlights the importance of different policy responses to the epidemics rather than a single set of policies.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
AbstractBackgroundPrescribing naloxone to patients is a key strategy to prevent opioid overdoses, but little is known about the reach of naloxone prescribing.ObjectiveDetermine patient factors associated with receiving naloxone and trends over time in patients with key overdose risk factors.DesignRetrospective observational study.ParticipantsUsing the Clinformatics DataMart, a US-wide health insurance claims dataset, we compared adults who received opioids and naloxone (opioid+naloxone) from January 2014 to June 2017 with adults who received opioids without naloxone (opioids only), matched on gender, age ± 5 years, ...
Source: Journal of General Internal Medicine - Category: Internal Medicine Source Type: research
Readers [1] have looked to recent publications in the Journal for insight on the risks of push-dose pressor (PDP) overdose [2,3]. These publications, especially the observational study of prefilled phenylephrine and ephedrine PDPs by Rotando et al., provide a valuable acknowledgement of the frequent errors and adverse effects (AEs) that occur. Reassuringly, no irreversible harm was described, and AEs were generally exaggerations of the desired hypertensive effects. However, larger overdoses can occur when PDP use is attempted with epinephrine 1  mg syringes than with prefilled PDPs, as 1000 μg phenylephrine may be e...
Source: The American Journal of Emergency Medicine - Category: Emergency Medicine Authors: Source Type: research
More News: Health Management | Overdose | Pharmaceuticals | Training | Universities & Medical Training